{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:23:42Z","timestamp":1790799822595,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000293","name":"Deafness Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000293","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.jcf.2014.07.009","type":"journal-article","created":{"date-parts":[[2014,8,13]],"date-time":"2014-08-13T03:00:52Z","timestamp":1407898852000},"page":"248-254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["High-frequency audiometry reveals high prevalence of aminoglycoside ototoxicity in children with cystic fibrosis"],"prefix":"10.1016","volume":"14","author":[{"given":"Ghada","family":"Al-Malky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally J.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Sirimanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanouil","family":"Bagkeris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjan","family":"Suri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jcf.2014.07.009_bb0005","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1128\/AAC.45.9.2502-2509.2001","article-title":"Occurrence and risk of cochleotoxicity in cystic fibrosis patients receiving repeated high-dose aminoglycoside therapy","volume":"45","author":"Mulheran","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.jcf.2014.07.009_bb0010","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.otohns.2009.03.020","article-title":"Sensorineural hearing loss in patients with cystic fibrosis","volume":"141","author":"Cheng","year":"2009","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"5","key":"10.1016\/j.jcf.2014.07.009_bb0015","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ijporl.2010.01.021","article-title":"Hearing loss in cystic fibrosis","volume":"74","author":"Martins","year":"2010","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"6","key":"10.1016\/j.jcf.2014.07.009_bb0020","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1164\/rccm.200109-012CC","article-title":"Aminoglycoside prescribing and surveillance in cystic fibrosis","volume":"167","author":"Tan","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.jcf.2014.07.009_bb0025","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/ppul.20985","article-title":"A survey of once-daily dosage tobramycin therapy in patients with cystic fibrosis","volume":"44","author":"Van Meter","year":"2009","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1016\/j.jcf.2014.07.009_bb0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1445-5994.2001.00010.x","article-title":"Aminoglycosides in cystic fibrosis: a descriptive study of current practice in Australia","volume":"31","author":"Phillips","year":"2001","journal-title":"Intern Med J"},{"issue":"11","key":"10.1016\/j.jcf.2014.07.009_bb0035","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1001\/archpedi.1989.02150230086028","article-title":"Aminoglycoside ototoxicity in cystic fibrosis. Evaluation by high-frequency audiometry","volume":"143","author":"McRorie","year":"1989","journal-title":"Am J Dis Child"},{"issue":"7","key":"10.1016\/j.jcf.2014.07.009_bb0040","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1128\/AAC.00995-05","article-title":"Absence of cochleotoxicity measured by standard and high-frequency pure tone audiometry in a trial of once- versus three-times-daily tobramycin in cystic fibrosis patients","volume":"50","author":"Mulheran","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.jcf.2014.07.009_bb0045","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00003446-200104000-00009","article-title":"High-frequency (8 to 16kHz) reference thresholds and intrasubject threshold variability relative to ototoxicity criteria using a Sennheiser HDA 200 earphone","volume":"22","author":"Frank","year":"2001","journal-title":"Ear Hear"},{"issue":"6","key":"10.1016\/j.jcf.2014.07.009_bb0050","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF02961666","article-title":"Aminoglycoside induced ototoxicity in patients with cystic fibrosis","volume":"160","author":"Mulherin","year":"1991","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.jcf.2014.07.009_bb0055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-4615-4897-3_4","article-title":"Aminoglycoside antibiotics. Structures, functions, and resistance","volume":"456","author":"Wright","year":"1998","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"10.1016\/j.jcf.2014.07.009_bb0060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000013861","article-title":"Aminoglycoside antibiotics","volume":"5","author":"Forge","year":"2000","journal-title":"Audiol Neurootol"},{"issue":"34","key":"10.1016\/j.jcf.2014.07.009_bb0065","doi-asserted-by":"crossref","first-page":"8588","DOI":"10.1200\/JCO.2004.00.5355","article-title":"Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development","volume":"23","author":"Knight","year":"2005","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.jcf.2014.07.009_bb0070","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3109\/14992027.2010.524253","article-title":"Aminoglycoside antibiotics cochleotoxicity in paediatric cystic fibrosis (CF) patients: a study using extended high-frequency audiometry and distortion product otoacoustic emissions","volume":"50","author":"Al-Malky","year":"2011","journal-title":"Int J Audiol"},{"issue":"7","key":"10.1016\/j.jcf.2014.07.009_bb0075","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/thx.2005.043539","article-title":"Cystic fibrosis: terminology and diagnostic algorithms","volume":"61","author":"De Boeck","year":"2006","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.jcf.2014.07.009_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00003446-199602000-00001","article-title":"High frequency hearing loss associated with otitis media","volume":"17","author":"Hunter","year":"1996","journal-title":"Ear Hear"},{"issue":"4","key":"10.1016\/j.jcf.2014.07.009_bb0085","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00003446-199908000-00007","article-title":"Distortion product otoacoustic emission test performance for a priori criteria and for multifrequency audiometric standards","volume":"20","author":"Gorga","year":"1999","journal-title":"Ear Hear"},{"issue":"4","key":"10.1016\/j.jcf.2014.07.009_bb0090","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/mpo.2950190415","article-title":"Cisplatin ototoxicity in children: a practical grading system","volume":"19","author":"Brock","year":"1991","journal-title":"Med Pediatr Oncol"},{"issue":"19","key":"10.1016\/j.jcf.2014.07.009_bb0095","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1200\/JCO.2011.39.1110","article-title":"Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new a","volume":"30","author":"Brock","year":"2012","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.jcf.2014.07.009_bb0100","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3109\/14992020309101328","article-title":"Immediate and short-term reliability of distortion-product otoacoustic emissions","volume":"42","author":"Beattie","year":"2003","journal-title":"Int J Audiol"},{"issue":"2","key":"10.1016\/j.jcf.2014.07.009_bb0105","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1001\/archotol.125.2.215","article-title":"High-frequency hearing influences lower-frequency distortion-product otoacoustic emissions","volume":"125","author":"Arnold","year":"1999","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"6","key":"10.1016\/j.jcf.2014.07.009_bb0110","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/AUD.0b013e318181ad99","article-title":"Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss","volume":"29","author":"Reavis","year":"2008","journal-title":"Ear Hear"},{"issue":"5","key":"10.1016\/j.jcf.2014.07.009_bb0115","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3109\/00206099809072982","article-title":"Extended high frequency audiometry in pre-school children","volume":"37","author":"Reuter","year":"1998","journal-title":"Audiology"},{"issue":"2","key":"10.1016\/j.jcf.2014.07.009_bb0120","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/01.AUD.0000120361.87401.C8","article-title":"Test\u2013retest reliability of pure-tone thresholds from 0.5 to 16kHz using Sennheiser HDA 200 and Etymotic Research ER-2 earphones","volume":"25","author":"Schmuziger","year":"2004","journal-title":"Ear Hear"},{"issue":"1","key":"10.1016\/j.jcf.2014.07.009_bb0125","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/AUD.0b013e318228a77d","article-title":"High-frequency pure-tone audiometry in children: a test\u2013retest reliability study relative to ototoxic criteria","volume":"33","author":"Beahan","year":"2012","journal-title":"Ear Hear"},{"issue":"4","key":"10.1016\/j.jcf.2014.07.009_bb0130","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1128\/AAC.31.4.594","article-title":"Cumulative and acute toxicity of repeated high-dose tobramycin treatment in cystic fibrosis","volume":"31","author":"Pedersen","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. 1","key":"10.1016\/j.jcf.2014.07.009_bb0135","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1258\/jrsm.2010.s11002","article-title":"Minimizing the toxicity of aminoglycosides in cystic fibrosis","volume":"103","author":"Smyth","year":"2010","journal-title":"J R Soc Med"},{"issue":"1","key":"10.1016\/j.jcf.2014.07.009_bb0140","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijantimicag.2010.02.018","article-title":"Risk factors for aminoglycoside ototoxicity in adult cystic fibrosis patients","volume":"36","author":"O'Donnell","year":"2010","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"10.1016\/j.jcf.2014.07.009_bb0145","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.ijporl.2014.02.015","article-title":"Normal hearing in a child with the m.1555A>G mutation despite repeated exposure to aminoglycosides. Has the penetrance of this pharmacogenetic interaction been overestimated?","volume":"78","author":"Al-Malky","year":"2014","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"9","key":"10.1016\/j.jcf.2014.07.009_bb0150","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1128\/AAC.31.9.1383","article-title":"Univariate and multivariate analyses of risk factors predisposing to auditory toxicity in patients receiving aminoglycosides","volume":"31","author":"Gatell","year":"1987","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199314001702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199314001702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:39:02Z","timestamp":1761601142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199314001702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S1569199314001702"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2014.07.009","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-frequency audiometry reveals high prevalence of aminoglycoside ototoxicity in children with cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2014.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}